Phase II Clinical Trial to test efficacy and safety of relapsed APL (JALSG APL205R study)
Phase 2
- Conditions
- relapsed acute promyelocytic leukemia (APL)
- Registration Number
- JPRN-C000000302
- Lead Sponsor
- Japan adult leukemia study group ( JALSG)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
1. Uncontrolled active infection 2. Past history of myocardial infarction or cardiac failure 3. Past history of renal failure 4. Uncontrolled diabetes mellitus 5. Liver cirrhosis 6. Abnormal reaction to ATO and AraC 7. Another severe and/or life threatening disease 8. Pregnant and/or lactating woman 9. Relapse after stem cell transplantation 10.Impossible to process this protocol
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method